PEG-IFN-SA

pegylated interferon-alpha

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PEG-IFN-SA, covering 2014-10-20 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease [Phase 1, Phase 2]